查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
生物可吸收聚合物的全球市場：按類型、應用、地區分類 - 到 2029 年的預測
市場調查報告書
商品編碼
1603239

生物可吸收聚合物的全球市場：按類型、應用、地區分類 - 到 2029 年的預測

Bioresorbable Polymers Market by Type (Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polylactic-co-glycolic acid (PLGA), Polycaprolactone (PCL)), Application (Orthopedic Devices, Drug Delivery), and Region - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 222 Pages | 訂單完成後即時交付

價格

生物可吸收聚合物市場規模預計將以 11.6% 的複合年成長率擴大，從 2024 年的 5 億美元成長到 2029 年的 8.672 億美元。

對醫療保健產業有利的政府法規和政策正在對生物可吸收聚合物市場產生積極影響。各國都制定了法規，鼓勵製造商提高醫療器材（例如整形外科器材）的生物相容性和生物分解性。這些變化正在推動生物可吸收聚合物的創造。外科植入的新技術正在推動對生物可吸收聚合物的需求。這正在推動企業進一步投資生物可吸收聚合物市場。

調查範圍
調查年份 2019-2029
基準年 2023年
預測期 2024-2029
目標單位 金額（百萬美元）和數量（個）
部分 按類型、用途和地區
目標區域 亞太地區、歐洲、北美、中東/非洲、南美

PCL 型細分市場預計將成為預測期內生物可吸收聚合物市場成長第三快的細分市場。這種需求主要是由藥物輸送系統的需求所驅動的。 PCL 的生物相容性和靈活性使其能夠靈活地適用於任何藥物傳輸形式，包括可注射微粒、可植入裝置和膠囊。它與其他生物可吸收聚合物的兼容性使其成為先進治療系統中定製配方的首選。

藥物傳輸領域是生物可吸收聚合物市場的第二大應用。推動這項需求的是對受控、標靶、緩釋性藥物系統的需求，進而改善患者的治療效果。生物可吸收聚合物也廣泛用於製備可植入藥物基質和膠囊，允許治療劑長期緩慢、受控釋放。這消除了重新給藥的需要，並顯著減少了患者的不適。這些聚合物具有高度生物相容性，這意味著它們可以在體內安全地分解，並符合醫療產業對創新、以患者為中心的醫療保健解決方案的推動。隨著世界各地對先進藥物傳輸系統的需求不斷增加，生物可吸收聚合物已成為創建高效且有效的治療解決方案的最重要選擇之一。

就 2023 年生物可吸收聚合物市場以金額為準，歐洲是第二大地區。該地區的生物可吸收聚合物市場相對成熟，成長速度慢於亞太和南美洲的新興市場。歐洲對生物可吸收聚合物的需求主要是因為癌症、心血管疾病、整形外科疾病和神經系統疾病等慢性疾病的盛行率不斷上升。肥胖、創傷、整形外科和心血管手術在歐洲也呈現上升趨勢。該地區擁有強大的醫療基礎設施，並正在進一步提升尖端醫學研究水平。這顯然增強了生物可吸收聚合物的市場，生物可吸收聚合物是植入和藥物傳輸系統的永續且生物相容的解決方案。此外，對基於生物分解性材料的醫療設備的監管支持也支持其在歐洲市場的發展。

該報告研究了全球生物可吸收聚合物市場，包括按類型、應用、地區和參與市場的公司概況分類的趨勢。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章市場概況

  • 介紹
  • 市場動態
  • 波特五力分析
  • 主要相關人員和採購標準
  • 總體經濟指標

第6章 產業趨勢

  • 供應鏈分析
  • 價格分析
  • 影響客戶業務的趨勢/干擾
  • 生態系分析
  • 技術分析
  • 案例研究分析
  • 貿易分析
  • 監管狀況
  • 2024-2025年重大會議和活動
  • 投資金籌措場景
  • 專利分析
  • 人工智慧/生成人工智慧對生物可吸收聚合物市場的影響

第7章生物可吸收聚合物市場（按類型）

  • 介紹
  • 聚乳酸（PLA）
  • Polyglycolic(PGA)
  • 聚乳酸乙醇酸 (PLGA)
  • 聚己內酯 (PCL)
  • 其他

第8章生物可吸收聚合物市場（依應用）

  • 介紹
  • 整形外科設備
  • 藥物輸送
  • 其他

第9章生物可吸收聚合物市場（按地區）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 俄羅斯
  • 中東/非洲
    • 中東
    • 非洲
  • 南美洲
    • 巴西
    • 阿根廷

第10章競爭格局

  • 介紹
  • 主要參與企業的策略/優勢
  • 市場佔有率分析
  • 收益分析
  • 企業評估矩陣：主要參與企業，2023
  • 企業評估矩陣：Start-Ups/小型企業，2023 年
  • 品牌/產品比較
  • 企業價值評估及財務指標
  • 競爭場景

第11章 公司簡介

  • 主要參與企業
    • CORBION
    • EVONIK INDUSTRIES AG
    • FOSTER CORPORATION
    • KLS MARTIN GROUP
    • DSM BIOMEDICAL
    • ASHLAND GLOBAL HOLDINGS INC.
    • ZEUS COMPANY LLC
    • SEQENS
    • REVA MEDICAL, LLC
    • POLY-MED INCORPORATED
  • 其他公司
    • BEZWADA BIOMEDICAL, LLC
    • NOMISMA HEALTHCARE PVT. LTD.
    • BMG INC.
    • POLYSCIENCES, INC.
    • HUIZHOU FORYOU MEDICAL DEVICES CO., LTD.
    • MUSASHINO CHEMICAL LABORATORY, LTD.
    • HENAN XINGHAN BIOLOGICAL TECHNOLOGY CO., LTD.

第12章 鄰近及相關市場

第13章附錄

Product Code: CH 4342

In terms of value, the bioresorbable polymers market is estimated to grow from USD 500.0 million in 2024 to USD 867.2 million by 2029, at a CAGR of 11.6%. Favorable regulations and policies by the government towards healthcare industry are positively influencing the bioresorbable polymers market. Various countries have created regulations that encourage manufacturers to increase biocompatibility & biodegradability of medical devices like orthopedic devices. These changes promote the creation of bioresorbable polymers. New technologies for the surgical implants are driving the demand for bioresorbable polymers. This further encourages businesses to invest in the bioresorbable polymers market.

Scope of the Report
Years Considered for the Study2019-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Million) and Volume (Unit)
SegmentsType, Application, and Region
Regions coveredAsia Pacific, Europe, North America, Middle East & Africa, and South America

"PCL type segment is projected to be the third-fastest growing segment of bioresorbable polymers market, during the forecast period"

PCL type segment is estimated to be the third-fastest growing segment of bioresorbable polymers market, during the forecast period. This demand is primarily due to its demand in drug delivery systems. The properties of biocompatibility and flexibility make PCL flexible and capable for use in any drug delivery format, such as injectable microparticles, implantable devices, and capsules. Compatibility with other bioresorbable polymers brings it as the first choice for customized formulations in advanced therapeutic systems.

"Drug delivery was the second largest end-use industry of bioresorbable polymers market, in terms of value, in 2023."

Drug delivery segment stands as the second-largest application in the bioresorbable polymers market. The demand is fueled by the need of controlled, targeted, and sustained-release drug systems, resulting in improved patient outcomes. Bioresorbable polymers are also widely employed in the preparation of implantable drug matrices and capsules to provide a slow and controlled release of therapeutic agents over time. This avoids the need for re-dose, thus significantly reducing discomfort to the patient. Their biocompatibility ensures that these polymers degrade safely within the body, well in line with the increasing trend by the medical industry towards innovative, patient-centered care solutions. With the desire for advanced drug delivery systems all over the world on the rise, bioresorbable polymers are among the most important choices when making efficient and effective therapeutic solutions.

"Europe was the second largest region in the bioresorbable polymers market, in terms of value."

Europe was the second-largest region in the bioresorbable polymers market, in terms of value, in 2023. The bioresorbable polymers market in the region is comparatively mature, growing slower than the developing markets in the Asia-Pacific region and South America. The demand of bioresorbable polymers in the European region is primarily due to the increasing prevalence of chronic diseases such as cancers, cardiovascular diseases, orthopedic disorders, and neurological conditions. Bariatric, trauma, orthopedic, and cardiovascular surgical procedures are also on the rise in Europe. The region has developed a strong health care infrastructure and increased the level of advanced medical research further, which has clearly enhanced this market for bioresorbable polymers offered as sustainable and biocompatible solutions for implants and drug delivery systems. Additionally, the support by regulatory towards biodegradable material-based medical devices helps to spread across the European market.

  • By Company Type: Tier 1 - 55%, Tier 2 - 25%, and Tier 3 - 20%
  • By Designation: Directors - 50%, Managers - 30%, and Others - 20%
  • By Region: North America - 40%, Europe - 35%, Asia Pacific - 20%, Rest of World - 5%

The key players profiled in the report include Corbion (Netherlands), Evonik Industries AG (Germany), Foster Corporation (US), KLS Martin Group (Germany), DSM Biomedical (US), Ashland Global Holdings Inc. (US), Zeus Company LLC (US), Seqens (France), Reva Medical, LLC (US), and Poly-Med Incorporated (US).

Research Coverage

This report segments the market for bioresorbable polymers based on type, application, and region and provides estimations of value (USD Million) for the overall market size across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, services, and key strategies, associated with the market for bioresorbable polymers.

Reasons to Buy this Report

This research report is focused on various levels of analysis - industry analysis (industry trends), market share analysis of top players, and company profiles, which together provide an overall view of the competitive landscape, emerging and high-growth segments of the bioresorbable polymers market; high-growth regions; and market drivers, restraints, and opportunities.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on bioresorbable polymers offered by top players in the global market
  • Analysis of key drivers: (Increasing number of surgical interventions, Boost in demand of biocompatible medical devices, Growing demand in drug delivery application, Favorable reimbursement scenario), opportunities (Electrospinning and 3D Printing Technologies), and challenges (Stringent regulatory framework for medical devices)
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the bioresorbable polymers market
  • Market Development: Comprehensive information about lucrative emerging markets - the report analyzes the markets for bioresorbable polymers across regions.
  • Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global bioresorbable polymers market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the bioresorbable polymers market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 DEFINITION AND INCLUSIONS, BY TYPE
    • 1.3.4 DEFINITION AND INCLUSIONS, BY APPLICATION
    • 1.3.5 YEARS CONSIDERED
    • 1.3.6 CURRENCY CONSIDERED
    • 1.3.7 UNITS CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Interviews with experts - demand and supply sides
      • 2.1.2.2 Key data from primary sources
      • 2.1.2.3 Key industry insights
      • 2.1.2.4 Breakdown of interviews with experts
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 TOP-DOWN APPROACH
    • 2.2.2 BOTTOM-UP APPROACH
  • 2.3 GROWTH FORECAST
    • 2.3.1 SUPPLY-SIDE FORECAST
    • 2.3.2 DEMAND-SIDE FORECAST
  • 2.4 FACTOR ANALYSIS
  • 2.5 DATA TRIANGULATION
  • 2.6 RESEARCH ASSUMPTIONS
  • 2.7 RESEARCH LIMITATIONS
  • 2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 SIGNIFICANT OPPORTUNITIES FOR PLAYERS IN BIORESORBABLE POLYMERS MARKET
  • 4.2 BIORESORBABLE POLYMERS MARKET, BY REGION
  • 4.3 NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY TYPE AND COUNTRY
  • 4.4 BIORESORBABLE POLYMERS MARKET, BY APPLICATION AND REGION
  • 4.5 BIORESORBABLE POLYMERS MARKET ATTRACTIVENESS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing number of surgical interventions
      • 5.2.1.2 Rising demand for biocompatible medical devices
      • 5.2.1.3 Growing demand for drug delivery applications
      • 5.2.1.4 Favorable reimbursement scenario
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Increasing preference for minimally invasive surgeries
      • 5.2.2.2 Higher cost of bioresorbable polymers than conventional polymers
      • 5.2.2.3 Lack of quality control measures in emerging countries
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Electrospinning and 3D printing technologies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Stringent regulatory framework for medical devices
      • 5.2.4.2 Requirement of skilled personnel for effective use of bioresorbable medical products
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • 5.3.1 THREAT OF NEW ENTRANTS
    • 5.3.2 THREAT OF SUBSTITUTES
    • 5.3.3 BARGAINING POWER OF SUPPLIERS
    • 5.3.4 BARGAINING POWER OF BUYERS
    • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.4.2 BUYING CRITERIA
  • 5.5 MACROECONOMIC INDICATORS
    • 5.5.1 GDP TRENDS AND FORECAST OF MOST PROMINENT ECONOMIES

6 INDUSTRY TRENDS

  • 6.1 SUPPLY CHAIN ANALYSIS
    • 6.1.1 RAW MATERIAL SUPPLIERS
    • 6.1.2 MANUFACTURERS
    • 6.1.3 DISTRIBUTORS
    • 6.1.4 END-USE INDUSTRIES
  • 6.2 PRICING ANALYSIS
    • 6.2.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION
    • 6.2.2 AVERAGE SELLING PRICE TREND, BY REGION
  • 6.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 6.4 ECOSYSTEM ANALYSIS
  • 6.5 TECHNOLOGY ANALYSIS
    • 6.5.1 KEY TECHNOLOGIES
      • 6.5.1.1 Electrospinning technology in bioresorbable polymers
    • 6.5.2 COMPLEMENTARY TECHNOLOGIES
      • 6.5.2.1 Melt extrusion technology
  • 6.6 CASE STUDY ANALYSIS
    • 6.6.1 BIORESORBABLE POLYMER SCAFFOLDS FOR TISSUE ENGINEERING
    • 6.6.2 BIORESORBABLE MATERIALS FOR CARDIOVASCULAR DEVICES
    • 6.6.3 BIORESORBABLE 3D-PRINTED PATIENT-SPECIFIC IMPLANTS FOR CRANIO-MAXILLOFACIAL SURGERY
  • 6.7 TRADE ANALYSIS
    • 6.7.1 IMPORT SCENARIO (HS CODE 390770)
    • 6.7.2 EXPORT SCENARIO (HS CODE 390770)
  • 6.8 REGULATORY LANDSCAPE
    • 6.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 6.8.2 REGULATORY FRAMEWORK
      • 6.8.2.1 Regulations impacting bioresorbable polymers business
      • 6.8.2.2 FDA guidelines for bioabsorbable polymers in medical devices
      • 6.8.2.3 REACH (Registration, evaluation, authorization and restriction of chemicals)
      • 6.8.2.4 ISO 10993 (Biological evaluation of medical devices)
      • 6.8.2.5 EU medical device regulation (MDR) for bioresorbable polymers
      • 6.8.2.6 ASTM standards for absorbable polymers and implants
  • 6.9 KEY CONFERENCES AND EVENTS, 2024-2025
  • 6.10 INVESTMENT AND FUNDING SCENARIO
  • 6.11 PATENT ANALYSIS
    • 6.11.1 APPROACH
    • 6.11.2 PATENT TYPES
    • 6.11.3 TOP APPLICANTS
    • 6.11.4 JURISDICTION ANALYSIS
  • 6.12 IMPACT OF AI/GEN AI ON BIORESORBABLE POLYMERS MARKET

7 BIORESORBABLE POLYMERS MARKET, BY TYPE

  • 7.1 INTRODUCTION
  • 7.2 POLYLACTIC ACID (PLA)
    • 7.2.1 RISING DEMAND FOR ORTHOPEDIC DEVICES TO DRIVE MARKET
  • 7.3 POLYGLYCOLIC ACID (PGA)
    • 7.3.1 USE IN SUTURES AND OTHER MEDICAL IMPLANTS TO PROPEL MARKET
  • 7.4 POLY (LACTIC-CO-GLYCOLIC ACID) (PLGA)
    • 7.4.1 BIOCOMPATIBILITY AND BIODEGRADABILITY TO DRIVE MARKET
  • 7.5 POLYCAPROLACTONE (PCL)
    • 7.5.1 DRUG DELIVERY, TISSUE ENGINEERING, AND ORTHOPEDIC DEVICE APPLICATIONS TO DRIVE MARKET
  • 7.6 OTHER TYPES

8 BIORESORBABLE POLYMERS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 ORTHOPEDIC DEVICES
    • 8.2.1 HIGH CONSUMPTION IN NORTH AMERICA AND EUROPE TO DRIVE MARKET
  • 8.3 DRUG DELIVERY
    • 8.3.1 SIGNIFICANT DEMAND FOR ORAL CAPSULES TO DRIVE MARKET
  • 8.4 OTHER APPLICATIONS

9 BIORESORBABLE POLYMERS MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 US
      • 9.2.1.1 Growing demand for orthopedic devices and drug delivery applications to drive market
    • 9.2.2 CANADA
      • 9.2.2.1 Increasing geriatric population to boost demand
    • 9.2.3 MEXICO
      • 9.2.3.1 Rising medical tourism to propel market growth
  • 9.3 ASIA PACIFIC
    • 9.3.1 CHINA
      • 9.3.1.1 Economic growth to be major driver for market growth
    • 9.3.2 JAPAN
      • 9.3.2.1 Rapidly aging population to drive market
    • 9.3.3 INDIA
      • 9.3.3.1 Growing pharmaceutical and medical industries to drive market
    • 9.3.4 SOUTH KOREA
      • 9.3.4.1 Increasing access to healthcare facilities to drive market
  • 9.4 EUROPE
    • 9.4.1 GERMANY
      • 9.4.1.1 Established healthcare industry and technological advancements offer opportunities for market growth
    • 9.4.2 UK
      • 9.4.2.1 Increasing healthcare expenditure to drive market growth
    • 9.4.3 ITALY
      • 9.4.3.1 Orthopedic and pharmaceutical applications to propel market
    • 9.4.4 FRANCE
      • 9.4.4.1 Initiatives to boost healthcare sector to drive demand
    • 9.4.5 RUSSIA
      • 9.4.5.1 Orthopedics, healthcare, and pharmaceutical segments contribute significantly to market growth
  • 9.5 MIDDLE EAST & AFRICA
    • 9.5.1 MIDDLE EAST
      • 9.5.1.1 Improving healthcare infrastructure to drive market
    • 9.5.2 AFRICA
      • 9.5.2.1 South Africa to be largest market
  • 9.6 SOUTH AMERICA
    • 9.6.1 BRAZIL
      • 9.6.1.1 Rising demand for implants in surgeries to drive market
    • 9.6.2 ARGENTINA
      • 9.6.2.1 Investments by major players to drive market

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 10.3 MARKET SHARE ANALYSIS
  • 10.4 REVENUE ANALYSIS
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 10.5.5.1 Company footprint
      • 10.5.5.2 Type footprint
      • 10.5.5.3 Application footprint
      • 10.5.5.4 Region footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 RESPONSIVE COMPANIES
    • 10.6.3 DYNAMIC COMPANIES
    • 10.6.4 STARTING BLOCKS
    • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
      • 10.6.5.1 Detailed list of key startups/SMEs
      • 10.6.5.2 Competitive benchmarking of key startups/SMEs
  • 10.7 BRAND/PRODUCT COMPARISON
  • 10.8 COMPANY VALUATION AND FINANCIAL METRICS
  • 10.9 COMPETITIVE SCENARIO
    • 10.9.1 PRODUCT LAUNCHES
    • 10.9.2 DEALS
    • 10.9.3 EXPANSIONS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
    • 11.1.1 CORBION
      • 11.1.1.1 Business overview
      • 11.1.1.2 Products/Solutions/Services offered
      • 11.1.1.3 Recent developments
        • 11.1.1.3.1 Deals
      • 11.1.1.4 MnM view
        • 11.1.1.4.1 Right to win
        • 11.1.1.4.2 Strategic choices
        • 11.1.1.4.3 Weaknesses and competitive threats
    • 11.1.2 EVONIK INDUSTRIES AG
      • 11.1.2.1 Business overview
      • 11.1.2.2 Products/Solutions/Services offered
      • 11.1.2.3 Recent developments
        • 11.1.2.3.1 Expansions
        • 11.1.2.3.2 Deals
      • 11.1.2.4 MnM view
        • 11.1.2.4.1 Right to win
        • 11.1.2.4.2 Strategic choices
        • 11.1.2.4.3 Weaknesses and competitive threats
    • 11.1.3 FOSTER CORPORATION
      • 11.1.3.1 Business overview
      • 11.1.3.2 Products/Solutions/Services offered
      • 11.1.3.3 MnM view
        • 11.1.3.3.1 Right to win
        • 11.1.3.3.2 Strategic choices
        • 11.1.3.3.3 Weaknesses and competitive threats
    • 11.1.4 KLS MARTIN GROUP
      • 11.1.4.1 Business overview
      • 11.1.4.2 Products/Solutions/Services offered
      • 11.1.4.3 MnM view
        • 11.1.4.3.1 Right to win
        • 11.1.4.3.2 Strategic choices
        • 11.1.4.3.3 Weaknesses and competitive threats
    • 11.1.5 DSM BIOMEDICAL
      • 11.1.5.1 Business overview
      • 11.1.5.2 Products/Solutions/Services offered
      • 11.1.5.3 MnM view
        • 11.1.5.3.1 Right to win
        • 11.1.5.3.2 Strategic choices
        • 11.1.5.3.3 Weaknesses and competitive threats
    • 11.1.6 ASHLAND GLOBAL HOLDINGS INC.
      • 11.1.6.1 Business overview
      • 11.1.6.2 Products/Solutions/Services offered
      • 11.1.6.3 Recent developments
        • 11.1.6.3.1 Product launches
        • 11.1.6.3.2 Expansions
    • 11.1.7 ZEUS COMPANY LLC
      • 11.1.7.1 Business overview
      • 11.1.7.2 Products/Solutions/Services offered
      • 11.1.7.3 Recent developments
        • 11.1.7.3.1 Product launches
    • 11.1.8 SEQENS
      • 11.1.8.1 Business overview
      • 11.1.8.2 Products/Solutions/Services offered
    • 11.1.9 REVA MEDICAL, LLC
      • 11.1.9.1 Business overview
      • 11.1.9.2 Products/Solutions/Services offered
    • 11.1.10 POLY-MED INCORPORATED
      • 11.1.10.1 Business overview
      • 11.1.10.2 Products/Solutions/Services offered
  • 11.2 OTHER PLAYERS
    • 11.2.1 BEZWADA BIOMEDICAL, LLC
    • 11.2.2 NOMISMA HEALTHCARE PVT. LTD.
    • 11.2.3 BMG INC.
    • 11.2.4 POLYSCIENCES, INC.
    • 11.2.5 HUIZHOU FORYOU MEDICAL DEVICES CO., LTD.
    • 11.2.6 MUSASHINO CHEMICAL LABORATORY, LTD.
    • 11.2.7 HENAN XINGHAN BIOLOGICAL TECHNOLOGY CO., LTD.

12 ADJACENT AND RELATED MARKETS

  • 12.1 INTRODUCTION
  • 12.2 LIMITATIONS
  • 12.3 POLY LACTIC ACID MARKET
    • 12.3.1 MARKET DEFINITION
    • 12.3.2 MARKET OVERVIEW
  • 12.4 POLY LACTIC ACID MARKET, BY REGION
    • 12.4.1 EUROPE
    • 12.4.2 NORTH AMERICA
    • 12.4.3 ASIA PACIFIC
    • 12.4.4 SOUTH AMERICA
    • 12.4.5 MIDDLE EAST & AFRICA

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 USD EXCHANGE RATES CONSIDERED, 2020-2023
  • TABLE 2 BIORESORBABLE POLYMERS MARKET: RISK ASSESSMENT
  • TABLE 3 TOTAL EXPENDITURE ON HEALTH, BY COUNTRY, 2015-2021 (% OF GDP)
  • TABLE 4 BIORESORBABLE POLYMERS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 5 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TYPES (%)
  • TABLE 6 KEY BUYING CRITERIA FOR TOP THREE TYPES
  • TABLE 7 GDP TRENDS AND FORECAST, BY KEY COUNTRY, 2021-2029 (USD BILLION)
  • TABLE 8 AVERAGE SELLING PRICE TREND OF BIORESORBABLE POLYMERS OFFERED BY KEY PLAYERS, BY APPLICATION, 2023 (USD/KG)
  • TABLE 9 AVERAGE SELLING PRICE TREND OF BIORESORBABLE POLYMERS, BY REGION, 2021-2029 (USD/KG)
  • TABLE 10 ROLES OF COMPANIES IN BIORESORBABLE POLYMERS ECOSYSTEM
  • TABLE 11 IMPORT DATA FOR HS CODE 390770-COMPLIANT PRODUCTS, BY REGION, 2019-2023 (USD THOUSAND)
  • TABLE 12 EXPORT DATA FOR HS CODE 390770-COMPLIANT PRODUCTS, BY REGION, 2019-2023 (USD THOUSAND)
  • TABLE 13 GLOBAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 BIORESORBABLE POLYMERS: LIST OF KEY CONFERENCES AND EVENTS, 2024-2025
  • TABLE 20 BIORESORBABLE POLYMERS MARKET: FUNDING/INVESTMENT SCENARIO
  • TABLE 21 BIORESORBABLE POLYMERS MARKET: PATENT STATUS, 2014-2024
  • TABLE 22 LIST OF MAJOR PATENTS FOR BIORESORBABLE POLYMERS, 2014-2024
  • TABLE 23 PATENTS BY GORE & ASSOCIATES, 2014-2024
  • TABLE 24 PATENTS BY KCI LICENSING INC., 2014-2024
  • TABLE 25 PATENTS BY LOCKE CHRISTOPHER BRIAN, 2014-2024
  • TABLE 26 TOP 10 PATENT OWNERS IN US, 2014-2024
  • TABLE 27 BIORESORBABLE POLYMERS MARKET, BY TYPE, 2017-2022 (USD MILLION)
  • TABLE 28 BIORESORBABLE POLYMERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 29 BIORESORBABLE POLYMERS MARKET, BY TYPE, 2017-2022 (TON)
  • TABLE 30 BIORESORBABLE POLYMERS MARKET, BY TYPE, 2023-2029 (TON)
  • TABLE 31 PLA-BASED BIORESORBABLE POLYMERS MARKET, BY REGION, 2017-2022 (USD MILLION)
  • TABLE 32 PLA-BASED BIORESORBABLE POLYMERS MARKET, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 33 PLA-BASED BIORESORBABLE POLYMERS MARKET, BY REGION, 2017-2022 (TON)
  • TABLE 34 PLA-BASED BIORESORBABLE POLYMERS MARKET, BY REGION, 2023-2029 (TON)
  • TABLE 35 PGA-BASED BIORESORBABLE POLYMERS MARKET, BY REGION, 2017-2022 (USD MILLION)
  • TABLE 36 PGA-BASED BIORESORBABLE POLYMERS MARKET, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 37 PGA-BASED BIORESORBABLE POLYMERS MARKET, BY REGION, 2017-2022 (TON)
  • TABLE 38 PGA-BASED BIORESORBABLE POLYMERS MARKET, BY REGION, 2023-2029 (TON)
  • TABLE 39 PLGA-BASED BIORESORBABLE POLYMERS MARKET, BY REGION, 2017-2022 (USD MILLION)
  • TABLE 40 PLGA-BASED BIORESORBABLE POLYMERS MARKET, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 41 PLGA-BASED BIORESORBABLE POLYMERS MARKET, BY REGION, 2017-2022 (TON)
  • TABLE 42 PLGA-BASED BIORESORBABLE POLYMERS MARKET, BY REGION, 2023-2029 (TON)
  • TABLE 43 PCL-BASED BIORESORBABLE POLYMERS MARKET, BY REGION, 2017-2022 (USD MILLION)
  • TABLE 44 PCL-BASED BIORESORBABLE POLYMERS MARKET, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 45 PCL-BASED BIORESORBABLE POLYMERS MARKET, BY REGION, 2017-2022 (TON)
  • TABLE 46 PCL-BASED BIORESORBABLE POLYMERS MARKET, BY REGION, 2023-2029 (TON)
  • TABLE 47 OTHER BIORESORBABLE POLYMER TYPES MARKET, BY REGION, 2017-2022 (USD MILLION)
  • TABLE 48 OTHER BIORESORBABLE POLYMER TYPES MARKET, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 49 OTHER BIORESORBABLE POLYMER TYPES MARKET, BY REGION, 2017-2022 (TON)
  • TABLE 50 OTHER BIORESORBABLE POLYMER TYPES MARKET, BY REGION, 2023-2029 (TON)
  • TABLE 51 BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (USD MILLION)
  • TABLE 52 BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 53 BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (TON)
  • TABLE 54 BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (TON)
  • TABLE 55 BIORESORBABLE POLYMERS MARKET IN ORTHOPEDIC DEVICES, BY REGION, 2017-2022 (USD MILLION)
  • TABLE 56 BIORESORBABLE POLYMERS MARKET IN ORTHOPEDIC DEVICES, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 57 BIORESORBABLE POLYMERS MARKET IN ORTHOPEDIC DEVICES, BY REGION, 2017-2022 (TON)
  • TABLE 58 BIORESORBABLE POLYMERS MARKET IN ORTHOPEDIC DEVICES, BY REGION, 2023-2029 (TON)
  • TABLE 59 BIORESORBABLE POLYMERS MARKET IN ORTHOPEDIC DEVICES, BY APPLICATION, 2017-2022 (USD MILLION)
  • TABLE 60 BIORESORBABLE POLYMERS MARKET IN ORTHOPEDIC DEVICES, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 61 BIORESORBABLE POLYMERS MARKET IN ORTHOPEDIC DEVICES, BY APPLICATION, 2017-2022 (TON)
  • TABLE 62 BIORESORBABLE POLYMERS MARKET IN ORTHOPEDIC DEVICES, BY APPLICATION, 2023-2029 (TON)
  • TABLE 63 BIORESORBABLE POLYMERS MARKET IN DRUG DELIVERY, BY REGION, 2017-2022 (USD MILLION)
  • TABLE 64 BIORESORBABLE POLYMERS MARKET IN DRUG DELIVERY, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 65 BIORESORBABLE POLYMERS MARKET IN DRUG DELIVERY, BY REGION, 2017-2022 (TON)
  • TABLE 66 BIORESORBABLE POLYMERS MARKET IN DRUG DELIVERY, BY REGION, 2023-2029 (TON)
  • TABLE 67 BIORESORBABLE POLYMERS MARKET IN DRUG DELIVERY, BY APPLICATION, 2017-2022 (USD MILLION)
  • TABLE 68 BIORESORBABLE POLYMERS MARKET IN DRUG DELIVERY, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 69 BIORESORBABLE POLYMERS MARKET IN DRUG DELIVERY, BY APPLICATION, 2017-2022 (TON)
  • TABLE 70 BIORESORBABLE POLYMERS MARKET IN DRUG DELIVERY, BY APPLICATION, 2023-2029 (TON)
  • TABLE 71 BIORESORBABLE POLYMERS MARKET IN OTHER APPLICATIONS, BY REGION, 2017-2022 (USD MILLION)
  • TABLE 72 BIORESORBABLE POLYMERS MARKET IN OTHER APPLICATIONS, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 73 BIORESORBABLE POLYMERS MARKET IN OTHER APPLICATIONS, BY REGION, 2017-2022 (TON)
  • TABLE 74 BIORESORBABLE POLYMERS MARKET IN OTHER APPLICATIONS, BY REGION, 2023-2029 (TON)
  • TABLE 75 BIORESORBABLE POLYMERS MARKET, BY REGION, 2017-2022 (USD MILLION)
  • TABLE 76 BIORESORBABLE POLYMERS MARKET, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 77 BIORESORBABLE POLYMERS MARKET, BY REGION, 2017-2022 (TON)
  • TABLE 78 BIORESORBABLE POLYMERS MARKET, BY REGION, 2023-2029 (TON)
  • TABLE 79 NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2017-2022 (USD MILLION)
  • TABLE 80 NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 81 NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2017-2022 (TON)
  • TABLE 82 NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2023-2029 (TON)
  • TABLE 83 NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (USD MILLION)
  • TABLE 84 NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 85 NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (TON)
  • TABLE 86 NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (TON)
  • TABLE 87 NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2017-2022 (USD MILLION)
  • TABLE 88 NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
  • TABLE 89 NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2017-2022 (TON)
  • TABLE 90 NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2023-2029 (TON)
  • TABLE 91 US: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (USD MILLION)
  • TABLE 92 US: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 93 US: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (TON)
  • TABLE 94 US: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (TON)
  • TABLE 95 CANADA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (USD MILLION)
  • TABLE 96 CANADA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 97 CANADA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (TON)
  • TABLE 98 CANADA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (TON)
  • TABLE 99 MEXICO: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (USD MILLION)
  • TABLE 100 MEXICO: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 101 MEXICO: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (TON)
  • TABLE 102 MEXICO: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (TON)
  • TABLE 103 ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2017-2022 (USD MILLION)
  • TABLE 104 ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 105 ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2017-2022 (TON)
  • TABLE 106 ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2023-2029 (TON)
  • TABLE 107 ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (USD MILLION)
  • TABLE 108 ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 109 ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (TON)
  • TABLE 110 ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (TON)
  • TABLE 111 ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2017-2022 (USD MILLION)
  • TABLE 112 ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
  • TABLE 113 ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2017-2022 (TON)
  • TABLE 114 ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2023-2029 (TON)
  • TABLE 115 CHINA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (USD MILLION)
  • TABLE 116 CHINA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 117 CHINA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (TON)
  • TABLE 118 CHINA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (TON)
  • TABLE 119 JAPAN: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (USD MILLION)
  • TABLE 120 JAPAN: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 121 JAPAN: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (TON)
  • TABLE 122 JAPAN: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (TON)
  • TABLE 123 INDIA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (USD MILLION)
  • TABLE 124 INDIA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 125 INDIA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (TON)
  • TABLE 126 INDIA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (TON)
  • TABLE 127 SOUTH KOREA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (USD MILLION)
  • TABLE 128 SOUTH KOREA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 129 SOUTH KOREA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (TON)
  • TABLE 130 SOUTH KOREA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (TON)
  • TABLE 131 EUROPE: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2017-2022 (USD MILLION)
  • TABLE 132 EUROPE: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 133 EUROPE: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2017-2022 (TON)
  • TABLE 134 EUROPE: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2023-2029 (TON)
  • TABLE 135 EUROPE: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (USD MILLION)
  • TABLE 136 EUROPE: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 137 EUROPE: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (TON)
  • TABLE 138 EUROPE: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (TON)
  • TABLE 139 EUROPE: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2017-2022 (USD MILLION)
  • TABLE 140 EUROPE: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
  • TABLE 141 EUROPE: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2017-2022 (TON)
  • TABLE 142 EUROPE: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2023-2029 (TON)
  • TABLE 143 GERMANY: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (USD MILLION)
  • TABLE 144 GERMANY: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 145 GERMANY: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (TON)
  • TABLE 146 GERMANY: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (TON)
  • TABLE 147 UK: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (USD MILLION)
  • TABLE 148 UK: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 149 UK: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (TON)
  • TABLE 150 UK: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (TON)
  • TABLE 151 ITALY: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (USD MILLION)
  • TABLE 152 ITALY: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 153 ITALY: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (TON)
  • TABLE 154 ITALY: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (TON)
  • TABLE 155 FRANCE: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (USD MILLION)
  • TABLE 156 FRANCE: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 157 FRANCE: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (TON)
  • TABLE 158 FRANCE: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (TON)
  • TABLE 159 RUSSIA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (USD MILLION)
  • TABLE 160 RUSSIA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 161 RUSSIA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (TON)
  • TABLE 162 RUSSIA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (TON)
  • TABLE 163 MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2017-2022 (USD MILLION)
  • TABLE 164 MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 165 MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2017-2022 (TON)
  • TABLE 166 MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2023-2029 (TON)
  • TABLE 167 MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (USD MILLION)
  • TABLE 168 MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 169 MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (TON)
  • TABLE 170 MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (TON)
  • TABLE 171 MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY REGION, 2017-2022 (USD MILLION)
  • TABLE 172 MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 173 MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY REGION, 2017-2022 (TON)
  • TABLE 174 MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY REGION, 2023-2029 (TON)
  • TABLE 175 MIDDLE EAST: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (USD MILLION)
  • TABLE 176 MIDDLE EAST: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 177 MIDDLE EAST: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (TON)
  • TABLE 178 MIDDLE EAST: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (TON)
  • TABLE 179 AFRICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (USD MILLION)
  • TABLE 180 AFRICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 181 AFRICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (TON)
  • TABLE 182 AFRICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (TON)
  • TABLE 183 SOUTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2017-2022 (USD MILLION)
  • TABLE 184 SOUTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 185 SOUTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2017-2022 (TON)
  • TABLE 186 SOUTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2023-2029 (TON)
  • TABLE 187 SOUTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (USD MILLION)
  • TABLE 188 SOUTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 189 SOUTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (TON)
  • TABLE 190 SOUTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (TON)
  • TABLE 191 SOUTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2017-2022 (USD MILLION)
  • TABLE 192 SOUTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
  • TABLE 193 SOUTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2017-2022 (TON)
  • TABLE 194 SOUTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2023-2029 (TON)
  • TABLE 195 BRAZIL: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (USD MILLION)
  • TABLE 196 BRAZIL: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 197 BRAZIL: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (TON)
  • TABLE 198 BRAZIL: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (TON)
  • TABLE 199 ARGENTINA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (USD MILLION)
  • TABLE 200 ARGENTINA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 201 ARGENTINA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017-2022 (TON)
  • TABLE 202 ARGENTINA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023-2029 (TON)
  • TABLE 203 BIORESORBABLE POLYMERS MARKET: OVERVIEW OF MAJOR STRATEGIES ADOPTED BY KEY PLAYERS, 2019-2024
  • TABLE 204 BIORESORBABLE POLYMERS MARKET: DEGREE OF COMPETITION, 2023
  • TABLE 205 BIORESORBABLE POLYMERS MARKET: TYPE FOOTPRINT
  • TABLE 206 BIORESORBABLE POLYMERS MARKET: APPLICATION FOOTPRINT
  • TABLE 207 BIORESORBABLE POLYMERS MARKET: REGION FOOTPRINT
  • TABLE 208 BIORESORBABLE POLYMERS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 209 BIORESORBABLE POLYMERS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 210 BIORESORBABLE POLYMERS MARKET: PRODUCT LAUNCHES, JANUARY 2020- OCTOBER 2024
  • TABLE 211 BIORESORBABLE POLYMERS MARKET: DEALS, JANUARY 2020-OCTOBER 2024
  • TABLE 212 BIORESORBABLE POLYMERS MARKET: EXPANSIONS, JANUARY 2020- OCTOBER 2024
  • TABLE 213 CORBION: COMPANY OVERVIEW
  • TABLE 214 CORBION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 215 CORBION: DEALS, JANUARY 2020-OCTOBER 2024
  • TABLE 216 EVONIK INDUSTRIES AG: COMPANY OVERVIEW
  • TABLE 217 EVONIK INDUSTRIES AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 218 EVONIK INDUSTRIES AG: EXPANSIONS, JANUARY 2020-OCTOBER 2024
  • TABLE 219 EVONIK INDUSTRIES AG: DEALS, JANUARY 2020-OCTOBER 2024
  • TABLE 220 FOSTER CORPORATION: COMPANY OVERVIEW
  • TABLE 221 FOSTER CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 222 KLS MARTIN GROUP: COMPANY OVERVIEW
  • TABLE 223 KLS MARTIN GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 224 DSM BIOMEDICAL: COMPANY OVERVIEW
  • TABLE 225 DSM BIOMEDICAL: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 226 ASHLAND GLOBAL HOLDINGS INC.: COMPANY OVERVIEW
  • TABLE 227 ASHLAND GLOBAL HOLDINGS INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 228 ASHLAND GLOBAL HOLDINGS INC.: PRODUCT LAUNCHES, JANUARY 2020- OCTOBER 2024
  • TABLE 229 ASHLAND GLOBAL HOLDINGS INC.: EXPANSIONS, JANUARY 2020-OCTOBER 2024
  • TABLE 230 ZEUS COMPANY LLC: COMPANY OVERVIEW
  • TABLE 231 ZEUS COMPANY LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 232 ZEUS COMPANY LLC: PRODUCT LAUNCHES, JANUARY 2020-OCTOBER 2024
  • TABLE 233 SEQENS: COMPANY OVERVIEW
  • TABLE 234 SEQENS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 235 REVA MEDICAL, LLC: COMPANY OVERVIEW
  • TABLE 236 REVA MEDICAL, LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 237 POLY-MED INCORPORATED: COMPANY OVERVIEW
  • TABLE 238 POLY-MED INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 239 BEZWADA BIOMEDICAL, LLC: COMPANY OVERVIEW
  • TABLE 240 NOMISMA HEALTHCARE PVT. LTD.: COMPANY OVERVIEW
  • TABLE 241 BMG INC.: COMPANY OVERVIEW
  • TABLE 242 POLYSCIENCES, INC.: COMPANY OVERVIEW
  • TABLE 243 HUIZHOU FORYOU MEDICAL DEVICES CO., LTD.: COMPANY OVERVIEW
  • TABLE 244 MUSASHINO CHEMICAL LABORATORY, LTD.: COMPANY OVERVIEW
  • TABLE 245 HENAN XINGHAN BIOLOGICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 246 POLY LACTIC ACID MARKET, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 247 POLY LACTIC ACID MARKET, BY REGION, 2023-2028 (USD MILLION)
  • TABLE 248 EUROPE: POLY LACTIC ACID MARKET, BY COUNTRY, 2019-2022 (USD MILLION)
  • TABLE 249 EUROPE: POLY LACTIC ACID MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
  • TABLE 250 NORTH AMERICA: POLY LACTIC ACID MARKET, BY COUNTRY, 2019-2022 (USD MILLION)
  • TABLE 251 NORTH AMERICA: POLY LACTIC ACID MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
  • TABLE 252 ASIA PACIFIC: POLY LACTIC ACID MARKET, BY COUNTRY, 2019-2022 (USD MILLION)
  • TABLE 253 ASIA PACIFIC: POLY LACTIC ACID MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
  • TABLE 254 SOUTH AMERICA: POLY LACTIC ACID MARKET, BY COUNTRY, 2019-2022 (USD MILLION)
  • TABLE 255 SOUTH AMERICA: POLY LACTIC ACID MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
  • TABLE 256 MIDDLE EAST & AFRICA: POLY LACTIC ACID MARKET, BY COUNTRY, 2019-2022 (USD MILLION)
  • TABLE 257 MIDDLE EAST & AFRICA: POLY LACTIC ACID MARKET, BY COUNTRY, 2023-2028 (USD MILLION)

List of Figures

  • FIGURE 1 BIORESORBABLE POLYMERS MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 BIORESORBABLE POLYMERS MARKET: RESEARCH DESIGN
  • FIGURE 3 APPROACH FOR BASE MARKET CALCULATION AND VALIDATION
  • FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 1 (TOP-DOWN)
  • FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 2 (SUPPLY SIDE)
  • FIGURE 6 BIORESORBABLE POLYMERS MARKET: SUPPLY-SIDE FORECAST
  • FIGURE 7 MARKET GROWTH PROJECTIONS FROM DEMAND-SIDE DRIVERS AND OPPORTUNITIES
  • FIGURE 8 FACTOR ANALYSIS OF BIORESORBABLE POLYMERS MARKET
  • FIGURE 9 BIORESORBABLE POLYMERS MARKET: DATA TRIANGULATION
  • FIGURE 10 PLA TO BE LARGEST BIORESORBABLE POLYMER TYPE DURING FORECAST PERIOD
  • FIGURE 11 DRUG DELIVERY TO BE FASTEST-GROWING APPLICATION OF BIORESORBABLE POLYMERS DURING FORECAST PERIOD
  • FIGURE 12 NORTH AMERICA ACCOUNTED FOR LARGEST SHARE OF BIORESORBABLE POLYMERS MARKET IN 2023
  • FIGURE 13 HIGH MARKET GROWTH EXPECTED IN EMERGING ECONOMIES DURING FORECAST PERIOD
  • FIGURE 14 NORTH AMERICA TO BE LARGEST BIORESORBABLE POLYMERS MARKET DURING FORECAST PERIOD
  • FIGURE 15 US ACCOUNTED FOR LARGEST MARKET SHARE IN NORTH AMERICA
  • FIGURE 16 ORTHOPEDIC DEVICES SEGMENT TO DOMINATE BIORESORBABLE POLYMERS MARKET DURING FORECAST PERIOD
  • FIGURE 17 INDIA TO BE FASTEST-GROWING BIORESORBABLE POLYMERS MARKET DURING FORECAST PERIOD
  • FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN BIORESORBABLE POLYMERS MARKET
  • FIGURE 19 PHARMACEUTICAL R&D EXPENDITURE IN EUROPE, US, JAPAN, AND CHINA, 2000-2022 (USD MILLION)
  • FIGURE 20 BIORESORBABLE POLYMERS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TYPES
  • FIGURE 22 KEY BUYING CRITERIA, BY TOP THREE TYPES
  • FIGURE 23 BIORESORBABLE POLYMERS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 24 AVERAGE SELLING PRICE TREND OF BIORESORBABLE POLYMERS OFFERED BY KEY PLAYERS, BY APPLICATION, 2023 (USD/KG)
  • FIGURE 25 AVERAGE SELLING PRICE TREND OF BIORESORBABLE POLYMERS, BY REGION, 2021-2029 (USD/KG)
  • FIGURE 26 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 27 BIORESORBABLE POLYMERS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 28 IMPORT DATA RELATED TO HS CODE 390770-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2019-2023 (USD THOUSAND)
  • FIGURE 29 EXPORT DATA RELATED TO HS CODE 390770-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2019-2023 (USD THOUSAND)
  • FIGURE 30 REGISTERED PATENTS RELATED TO BIORESORBABLE POLYMERS, 2014-2024
  • FIGURE 31 TOP PATENT OWNERS DURING LAST 10 YEARS, 2014-2024
  • FIGURE 32 LEGAL STATUS OF PATENTS FILED FOR BIORESORBABLE POLYMERS, 2014-2024
  • FIGURE 33 MAXIMUM PATENTS FILED IN US JURISDICTION, 2014-2024
  • FIGURE 34 PLGA TO BE FASTEST-GROWING SEGMENT DURING FORECAST PERIOD
  • FIGURE 35 ASIA PACIFIC TO BE FASTEST-GROWING BIORESORBABLE POLYMERS MARKET FOR PLA SEGMENT
  • FIGURE 36 NORTH AMERICA TO BE LARGEST PGA-BASED BIORESORBABLE POLYMERS MARKET DURING FORECAST PERIOD
  • FIGURE 37 ASIA PACIFIC TO BE FASTEST-GROWING PLGA-BASED BIORESORBABLE POLYMERS MARKET DURING FORECAST PERIOD
  • FIGURE 38 EUROPE TO BE SECOND-LARGEST MARKET FOR PCL-BASED BIORESORBABLE POLYMERS BETWEEN 2024 AND 2029
  • FIGURE 39 ASIA PACIFIC TO BE FASTEST-GROWING MARKET FOR OTHER BIORESORBABLE POLYMER TYPES DURING FORECAST PERIOD
  • FIGURE 40 ORTHOPEDIC DEVICES TO BE LARGEST APPLICATION OF BIORESORBABLE POLYMERS DURING FORECAST PERIOD
  • FIGURE 41 NORTH AMERICA TO BE LARGEST MARKET FOR BIORESORBABLE POLYMERS IN ORTHOPEDIC DEVICES APPLICATION
  • FIGURE 42 NORTH AMERICA TO BE LARGEST BIORESORBABLE POLYMERS MARKET IN DRUG DELIVERY APPLICATION
  • FIGURE 43 EUROPE TO BE SECOND-LARGEST BIORESORBABLE POLYMERS MARKET IN OTHER APPLICATIONS
  • FIGURE 44 ASIA PACIFIC TO BE FASTEST-GROWING BIORESORBABLE POLYMERS MARKET DURING FORECAST PERIOD
  • FIGURE 45 NORTH AMERICA: BIORESORBABLE POLYMERS MARKET SNAPSHOT
  • FIGURE 46 ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET SNAPSHOT
  • FIGURE 47 EUROPE: BIORESORBABLE POLYMERS MARKET SNAPSHOT
  • FIGURE 48 BIORESORBABLE POLYMERS MARKET SHARE ANALYSIS, 2023
  • FIGURE 49 BIORESORBABLE POLYMERS MARKET: REVENUE ANALYSIS OF KEY PLAYERS (USD MILLION), 2019-2023
  • FIGURE 50 BIORESORBABLE POLYMERS MARKET: COMPANY EVALUATION MATRIX, KEY PLAYERS, 2023
  • FIGURE 51 BIORESORBABLE POLYMERS MARKET: COMPANY FOOTPRINT
  • FIGURE 52 BIORESORBABLE POLYMERS MARKET: COMPANY EVALUATION MATRIX, STARTUPS/SMES, 2023
  • FIGURE 53 BIORESORBABLE POLYMERS MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 54 BIORESORBABLE POLYMERS MARKET: EV/EBITDA OF KEY MANUFACTURERS
  • FIGURE 55 BIORESORBABLE POLYMERS MARKET: ENTERPRISE VALUATION OF KEY PLAYERS (USD BILLION)
  • FIGURE 56 CORBION: COMPANY SNAPSHOT
  • FIGURE 57 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT
  • FIGURE 58 ASHLAND GLOBAL HOLDINGS INC.: COMPANY SNAPSHOT